BRIEF-CVS Caremark CFO sees Q1 net revenue down 2.5-4 percent due to growth in generic drugs

CHICAGO Thu Dec 13, 2012 8:50am EST

CHICAGO Dec 13 (Reuters) - CVS Caremark Corp : * CFO sees Q1 net revenue down 2.5-4 percent due to growth in generic drugs * CFO sees Q1 adjusted EPS $0.77-$0.80 * Thomson Reuters I/B/E/S Q1 earnings per share view $0.74 * Thomson Reuters I/B/E/S Q1 revenue view $31.98 billion * Sees Q1 same-store sales down 2-3.5 percent

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.